SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Lux Encore Sponsor, LP (Last) (First) (Middle) C/O LUX HEALTH TECH ACQUISITION CORP. 920 BROADWAY, 11TH FLOOR (Street) NEW YORK NY 10010 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 10/26/2020	3. Issuer Name and Ticker or Trading Symbol Lux Health Tech Acquisition Corp. [ LUXA ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B Common Stock	(1)	(1)	Class A Common Stock	8,505,000	(1)	I	See footnote(2)

1. Name and Address of Reporting Person* Lux Encore Sponsor, LP (Last) (First) (Middle) C/O LUX HEALTH TECH ACQUISITION CORP. 920 BROADWAY, 11TH FLOOR (Street) NEW YORK NY 10010 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Lux Encore Holdings, LLC (Last) (First) (Middle) C/O LUX HEALTH ACQUISITION CORP. 920 BROADWAY, 11TH FLOOR (Street) NEW YORK NY 10010 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Wolfe Josh (Last) (First) (Middle) C/O LUX HEALTH ACQUISITION CORP. 920 BROADWAY, 11TH FLOOR (Street) NEW YORK NY 10010 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Hebert Peter (Last) (First) (Middle) C/O LUX HEALTH ACQUISITION CORP. 920 BROADWAY, 11TH FLOOR (Street) NEW YORK NY 10010 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer X Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. The Class B common stock will automatically convert into shares of Class A common stock at the completion of the Issuer's initial business combination on a one-for-one basis, subject to adjustment.

2. Lux Encore Sponsor, LP ("Sponsor") is the record holder of the shares reported herein. Lux Encore Holdings, LLC ("Lux GP") is the general partner of Sponsor. Josh Wolfe and Peter Hebert are the managing members of Lux GP. As such, Lux GP and each of Messers. Wolfe and Hebert may be deemed to share beneficial ownership of the Class B common stock held directly by Sponsor. Lux GP and Messers. Wolfe and Hebert disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein.

Remarks:

Exhibit List Exhibit 24.1 - Power of Attorney Exhibit 24.2 - Power of Attorney

	Lux Encore Sponsor, LP, By: Lux Encore Holdings, LLC, its general partner, By: /s/ Segolene Scarborough, Attorney-in-Fact for Peter Hebert, Managing Member, By: /s/ Segolene Scarborough, Attorney-in-Fact for Josh Wolfe, Managing Member	10/26/2020
	Lux Encore Holdings, LLC, By: /s/ Segolene Scarborough, Attorney-in-Fact for Peter Hebert, Managing Member, By: /s/ Segolene Scarborough, Attorney-in-Fact for Josh Wolfe, Managing Member	10/26/2020
	/s/ Segolene Scarborough, Attorney-in-Fact for Josh Wolfe	10/26/2020
	/s/ Segolene Scarborough, Attorney-in-Fact for Peter Hebert	10/26/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.